PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsJubilant Therapeutics
Jubilant Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AlendronateAlendronate2010-02-182031
AmantadineAmantadine2018-02-072025-2038
Amlodipine olmesartan medoxomilAmlodipine besylate, Olmesartan medoxomil2017-05-15
—
BupropionBupropion2013-10-112024-2043
CarbamazepineCarbamazepine1988-02-012024-2040
CelecoxibCelecoxib2017-04-042029-2038
CetirizineCetirizine2015-02-192030-2032
CitalopramCitalopram2015-12-23
ClomipramineClomipramine2019-10-21
ClonidineClonidine2018-01-292027-2031
CyclobenzaprineCyclobenzaprine2006-04-19
DarifenacinDarifenacin2016-10-12
1
2
3
4
5
6
7
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sodium iodide i 131
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use